Department: 
Biochemistry
Pseudonyms: 
RCF
Test Code: 
RCF
Availability: 
Unavailable
Collection Requirements: 
Not available (refer to notes)
Requires own tube?: 
No
Notes: 
Red cell folate is not offered, serum folate is the preferred test. Please contact the laboratory for discussion if required.
Publications
Date of Publication: Jun 2016
Sonpavde, G., Pond, G. R., Templeton, A. J., Fandi, A., Tombal, B., Rosenthal, M., Armstrong, A. J., Petrylak, D. P.
We explored the association between Response Evaluation Criteria in Solid Tumors (RECIST) 1.0 and 1.1 changes and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) from the control arms of the VENICE and MAINSAIL phase 3 trials, respectively, receiving docetaxel, prednisone, and placebo.
Publications
Date of Publication: Apr 2014
Skouteris, H., Morris, H., Nagle, C., Nankervis, A.
The prevalence of gestational diabetes mellitus (GDM) and obesity is increasing in developed countries, presenting significant challenges to acute care and public health. The aim of this study is to systematically review published controlled trials evaluating behavior modification interventions to prevent the development of GDM.
Publications
Date of Publication: Feb 2018
Cook, A. D., Hamilton, J. A.
Mavrilimumab (formerly CAM-3001) is a high-affinity, immunoglobulin G4 monoclonal antibody (mAb) against the granulocyte macrophage colony-stimulating factor (GM-CSF) receptor-alpha chain. Phase I and II trials in patients with rheumatoid arthritis (RA) treated with mavrilimumab have shown encouraging results with respect to both safety and efficacy.
Publications
Date of Publication: Jun 2018
Wilder-Smith, A., Vannice, K., Durbin, A., Hombach, J., Thomas, S. J., Thevarjan, I., Simmons, C. P.
Background: Various Zika virus (ZIKV) vaccine candidates are currently in development. Nevertheless, unique challenges in clinical development and regulatory pathways may hinder the licensure of high-quality, safe, and effective ZIKV vaccines.
Department: 
Microbiology
Laboratory: 
Microbiology
Tube Colour: 
Yellow top universal
Pseudonyms: 
Synovial Fluid culture/microscopy
Test Code: 
FL
Availability: 
Daily
Collection Requirements: 
Aspirate in Sterile Container
Requires own tube?: 
No
Internal Spec Code: 
FL
Fee: 
Medicare rebatable
Notes: 
If cell count required send additional 1 mL aspirate in an EDTA tube
Department: 
Biochemistry
Tube Colour: 
Gold
Light Green
Pseudonyms: 
TRYP, Mast Cell Tryptase
Test Code: 
TRYP
Availability: 
Weekly
Collection Requirements: 
8.5 ml Serum or 4.5 ml Lithium Heparin
Requires own tube?: 
No
Reference Range: 
=<11.0ug/L represents 95% upper percentile of normal
Publications
Date of Publication: Nov 2018
Lewin, S. R.
Antiviral drugs prevent HIV from replicating, but the virus can hide in the cells of infected individuals in a non-replicating, latent form. A two-pronged approach to target this latent virus shows promise in monkeys.
Publications
Date of Publication: Jul 2017
Ong, K. L., O',Connell, R., Januszewski, A. S., Jenkins, A. J., Xu, A. M., Sullivan, D. R., Barter, P. J., Scott, R. S., Taskinen, M. R., Waldman, B., Colman, P. G., Best, J. D., Simes, J. R., Rye, K. A., Keech, A. C., Field Study Investigators
BACKGROUND: It is not known whether circulating fibroblast growth factor 21 (FGF21) concentrations are associated with glycemic progression in patients with established type 2 diabetes. This study reports this relationship in type 2 diabetes patients participating in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial.
Publications
Date of Publication: Oct 2017
Smesny, S., Milleit, B., Schaefer, M. R., Hesse, J., Schlogelhofer, M., Langbein, K., Hipler, U. C., Berger, M., Cotter, D. R., Sauer, H., McGorry, P. D., Amminger, G. P.
Alterations of immune function have been reported in ultra-high risk (UHR) for psychosis patients causing expectations in terms of predictive meaningfulness and benefits of anti-inflammatory agents. According to a RCT in UHR-patients supplementation of omega-3 polyunsaturated fatty acids (PUFA) was effective in reducing transition to psychosis risk and to improve symptomatology.
Search results found: 2338